Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Inactive hair follicle stem cells help prevent skin cancer.

Neuregulin3 affects cell development in the skin and mammary glands.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

ΔNp63α stops TAp73β from working in skin cancer by blocking its access to specific genes, not by directly interacting with it.

New treatments for hair loss may target specific pathways and generate new hair follicles.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Pantethine may boost the immune system's ability to fight sarcoma.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.